Format: Grand Rounds

1-5 of 5 Activities
Title
Availability
Format
Credits
Launch Date
Buttons
Live
Grand Rounds
1
12/20/2024 at 12:00 PM EST

Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer

In this Grand Rounds activity, a breast cancer expert will guide participants through a discussion of criteria to select patients to receive ADCs, adverse event (AE) management, and strategies to foster equitable care of patients with metastatic breast cancer (mBC).

1
12/20/2024 at 12:00 PM EST

Yara Abdou, MD

Yara Abdou, MD

Live
Grand Rounds
1
11/20/2024 at 7:00 PM EST

Tailoring Patient Care Using Novel Agents in Metastatic Urothelial Carcinoma: Strategies for the Interprofessional Team

Join our expert faculty for this 60-minute activity designed to help clinicians stay abreast of emerging trial data and evolving treatment guidelines, as well as effectively manage agent-specific AEs, to optimize care for their patients with mUC.

1
11/20/2024 at 7:00 PM EST

Petros Grivas, MD, PhD

Petros Grivas, MD, PhD

Live
Grand Rounds
1
12/05/2024 at 12:00 PM EST

Tailoring Patient Care Using Novel Agents in Metastatic Urothelial Carcinoma: Strategies for the Interprofessional Team

Join our expert faculty for this 60-minute activity designed to help clinicians stay abreast of emerging trial data and evolving treatment guidelines, as well as effectively manage agent-specific AEs, to optimize care for their patients with mUC.

1
12/05/2024 at 12:00 PM EST

Robert Dreicer, MD, MS, MACP, FASCO

Robert Dreicer, MD, MS, MACP, FASCO

Live
Grand Rounds
1
11/15/2024 at 12:00 PM EST

Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer

In this Grand Rounds activity, a breast cancer expert will guide participants through a discussion of criteria to select patients to receive ADCs, adverse event (AE) management, and strategies to foster equitable care of patients with metastatic breast cancer (mBC).

1
11/15/2024 at 12:00 PM EST

Sara Tolaney, MD, MPH

Sara Tolaney, MD, MPH

On-Demand
Grand Rounds
1
07/02/2024

Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer

In this Grand Rounds activity, a breast cancer expert will guide participants through a discussion of criteria to select patients to receive ADCs, adverse event (AE) management, and strategies to foster equitable care of patients with metastatic breast cancer (mBC).

1
07/02/2024

Sara Tolaney, MD, MPH

Sara Tolaney, MD, MPH